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Salisbury, United Kingdomc; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdomd; Department of Biochemistry, Yong Loo
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ABSTRACT The opportunistic pathogenAcinetobacter baumannii is able to persist in the environment and is oftenmultidrug resis-
tant (MDR), causing difficulties in the treatment of infections.Here, we show that the two-component systemAdeRS,which regulates
the production of the AdeABCmultidrug resistance efflux pump, is required for the formation of a protective biofilm in an ex vivo
porcinemucosalmodel, whichmimics a natural infection of the human epithelium. Interestingly, deletion of adeB impacted only on
the ability of strainAYE to form a biofilmonplastic and only on the virulence of strain Singapore 1 forGalleriamellonella. RNA-Seq
revealed that loss of AdeRS orAdeB significantly altered the transcriptional landscape, resulting in the changed expression ofmany
genes, notably those associatedwith antimicrobial resistance and virulence interactions. For example,A. baumannii lacking AdeRS
displayed decreased expression of adeABC, pil genes, com genes, and a pgaC-like gene, whereas loss of AdeB resulted in increased ex-
pression of pil and com genes anddecreased expression of ferric acinetobactin transport systemgenes. These data define the scope of
AdeRS-mediated regulation, show that changes in the production ofAdeABCmediate important phenotypes controlled byAdeRS, and
suggest that AdeABC is a viable target for antimicrobial drug and antibiofilmdiscovery.
IMPORTANCE Acinetobacter baumannii is a nosocomial pathogen and is an increasing problem in hospitals worldwide. This
organism is often multidrug resistant, can persist in the environment, and forms a biofilm on environmental surfaces and
wounds. Overproduction of efflux pumps can allow specific toxic compounds to be pumped out of the cell and can lead to multi-
drug resistance. This study demonstrates the role of the A. baumannii efflux pump AdeB, and its regulator AdeRS, in multidrug
resistance, epithelial cell killing, and biofilm formation. Deletion of the genes encoding these systems led to increased suscepti-
bility to antibiotics, decreased biofilm formation on biotic and abiotic surfaces, and decreased virulence. Our data suggest that
inhibition of AdeB could prevent biofilm formation or colonization in patients by A. baumannii and provides a good target for
drug discovery.
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Acinetobacter baumannii is an opportunistic pathogen thatcommonly causes nosocomial infections, such as ventilator-
associated pneumonia and skin, soft tissue, wound, and blood-
stream infections (1). There are several factors that contribute to
the environmental persistence of, and infection by, this organism.
These include its propensity to resist desiccation and survive in the
hospital environment (2, 3) and its ability to form biofilms on
both medical devices and biological surfaces (4–7). A. baumannii
isolates are often resistant to high concentrations of antimicrobial
drugs because of both intrinsic and acquiredmechanisms, such as
increased production ofmultidrug resistance (MDR) efflux pump
proteins (8–10).
Bacterial cells often exist as a biofilm, where cells are attached
to a surface and enclosed in an extracellular matrix that can be
composed of polysaccharides, extracellular DNA, and protein.
Biofilms are significantly more resistant to antimicrobial treat-
ment, host immune responses, desiccation, and UV light, which
enables them to persist in harsh environments, including the hos-
pital setting. Growth on medical devices and tissue surfaces can
lead to biofilm formation and increase the risk of bloodstream and
respiratory infections, as the biofilm acts as a reservoir of bacteria
(11). In vitro studies have shown that biofilms can survive antibi-
otic concentrations of up to 1,000 times the MIC for a planktonic
culture, and in vivo, bacteria that survive antibiotic exposure in a
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biofilm state can cause recurrence of infection once antibiotic
treatment is stopped (12, 13). It is hypothesized that biofilm resis-
tance to antimicrobial therapy is due to multiple factors: the slow
penetration of the biofilm by the antibiotic, the heterogeneity of
the biofilm creating an altered microenvironment in which anti-
biotics are less effective, the differentiation of biofilm cells into a
protected slow-growing state including a large proportion of “per-
sister cells,” and changed gene expression due to this altered
growth state (12–15). Bacteria in a sessile state exhibit proteomic
profiles distinct from those of their planktonic counterparts, sug-
gesting that these cells differ functionally and physically (16).
Analysis of the transcriptome of A. baumannii in planktonic and
biofilm states has revealed distinct and specific expression pat-
terns and demonstrated the complexity of the networks regulating
biofilm formation (17–20). Increased expression of resistance-
nodulation-division (RND) efflux pump genes in biofilm versus
planktonic states was also seen (17). Although several genes in-
volved in biofilm pathways have been identified in A. baumannii
(4–7), relatively little is known about the factors controlling bio-
film formation or their contribution to virulence in this pathogen.
Expression of factors involved in biofilm formation can vary
widely, depending on the model system used (18–21). Therefore,
it is essential that clinically relevant model systems be used to
evaluate themicrobial factors that contribute to infectious biofilm
formation.
BacterialMDR efflux pumps can extrude a broad range of sub-
strates from the cell, conferring resistance to numerous antibiot-
ics, biocides, dyes, and detergents. Increased expression of MDR
efflux pump genes such as Acinetobacter RND efflux pump genes
adeABC leads toMDR and is commonly seen in clinical isolates of
A. baumannii (8, 22). Changes in the expression levels of these
MDR efflux pump genes are often due to mutations in the genes
encoding the two-component system (TCS) AdeRS, which regu-
lates adeABC (22). Mutations in adeRS can cause overproduction
of AdeABC and lead to MDR (8, 22). Deletion of either adeR or
adeS from isolates overexpressing adeABC results in increased sus-
ceptibility to antimicrobials and other substrates of this pump
(22). Bacterial TCSs have previously been shown to be involved in
the regulation of various functions, such as growth, competence,
metabolism, adaptation to starvation, osmoregulation, and ex-
pression of toxins (23).
In this study, we investigated the effect of deletion of adeRS and
adeB on antimicrobial susceptibility and the abilities of two
A. baumannii strains to form a biofilm on abiotic and biotic sur-
faces and cause infection in Galleria mellonella. The transcrip-
tomes ofA. baumannii strains AYE (24) and Singapore 1 (S1) (25)
and adeRS and adeB mutants thereof were determined by RNA
sequencing (RNA-Seq). This allowed a distinction to be made
between the effects of adeB deletion and those of adeRS deletion.
Multiple genes encoding proteins with potential functions includ-
ing drug resistance, biofilm formation, and virulence, such as
those encoding RND efflux pumps, type IV pili, DNA uptake
channels, and acinetobactin transport systems, were differentially
expressed in these mutants.
RESULTS
Choice of strains for this study. In this study,we usedA. bauman-
nii strain AYE as a well-characterized isolate that is MDR because
of an Ala94Val mutation in adeS that has been previously associ-
ated with increased expression of adeABC (10, 26). A clinical iso-
late from Singapore, S1, that was more susceptible to antimicro-
bials than strain AYE was and had no mutation in adeS and
therefore did not express a high level of adeABC was also studied.
Together, these strains represent clones that are internationally
successful (strain AYE is sequence type 1 [ST1] of international
clone I, and S1 is ST40 and representative of strains causing infec-
tions in Southeast Asia) (see Fig. S1 in the supplementalmaterial).
Type strainATCC19606 (ST52)was included as a control in the ex
vivo biofilm experiments as a strain that has a well-characterized
biofilm phenotype (21, 27). Deletion of adeRS was carried out by
a markerless deletion method (28). It was hypothesized that the
phenotype displayed by AYEadeRS might be due to decreased
production of the tripartite MDR RND efflux pump AdeABC (as
observed by RNA-Seq). To distinguish between the role of AdeRS
and that of AdeABC in drug resistance, biofilm formation, and
virulence in A. baumannii, an AdeB efflux pump deletion mutant
of strainAYE and anAdeAB efflux pumpdeletionmutant of strain
S1 were created. Gene deletion was confirmed by PCR and Sanger
sequencing.
Deletion of adeRS reduces susceptibility to antimicrobials
and dyes and reduces levels of efflux in AYE. Growth curves,
determined by measuring the optical density (OD) of the culture
over time, showed no difference in growth rate between strain
AYE and the adeRS mutant (see Fig. S2 in the supplemental ma-
terial). However, deletion of adeRS resulted in a change in the
drug resistance profile of strain AYE. There was a decrease in the
MICs of imipenem, kanamycin, gentamicin, ciprofloxacin, tetra-
cycline, tigecycline, chloramphenicol, and ethidium bromide
upon the deletion of adeRS from strain AYE such that the pheno-
type of the mutant was similar to that of an adeB mutant of the
same strain (Table 1). Although some of these changes were only
2-fold, which is considered to be the margin of error of this
method, these changes were consistent in multiple experiments
and were confirmed by growth kinetics in the presence of antibi-
otics (see Fig. S3 in the supplemental material). We have previ-
TABLE 1 MICs of dyes and antibiotics used in this study
Dye or
antibiotica
MICb (g/ml) for:
AYE AYEadeRS AYEadeB S1 S1adeAB
AMP 1,024 1,024 1,024 16 16
TAZ 1,024 1,024 1,024 1,024 1,024
IMP 1.5 0.75 0.75 0.125 0.125
MER 0.25 0.25 0.125 0.94 0.94
KAN 1,024 512 256 1 1
GEN 128 8 4 0.25 0.25
NOR 128 128 128 2 2
CIP 128 32 32 0.25 0.25
COL 1 1 1 0.5 0.5
TET 256 128 128 4 4
TIG 1 0.25 0.25 0.12 0.12
CHL 512 256 256 128 128
CCCP 32 32 16 16 16
PAN 1,024 1,024 512 512 128
EtBrb 512 256 128 256 256
a AMP, ampicillin, TAZ, ceftazidime, IMP, imipenem; MER, meropenem; KAN,
kanamycin, GEN, gentamicin, NOR, norfloxacin, CIP, ciprofloxacin, COL, colistin,
TET, tetracycline, TIG, tigecycline, CHL, chloramphenicol; CCCP, carbonyl cyanide
m-chlorophenylhydrazone; PAN, phenylalanine-arginine beta-napthalymide; EtBr,
ethidium bromide.
b Values in bold indicate significant differences between the mutant and parental
strains.
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ously showed that accumulation of the dye Hoechst 33342
(H33342) is a good indication of efflux activity in A. baumannii
(25). Accumulation of H33342 in strain AYEadeRS was 40%
greater than that in strain AYE (P  0.05), indicating reduced
levels of efflux in the mutant (Fig. 1). Similar results were seen
with efflux of ethidium bromide (data not shown).
DeletionofadeRS inAYEresults indecreasedbiofilm forma-
tion on mucosal tissue. We used an ex vivo porcine vaginal mu-
cosa (PVM)model tomimic a biofilm infection of humanmucosa
(20, 29, 30). To determine whether strain AYE showed a biofilm
phenotype similar to that of a previously characterized biofilm-
forming type strain ofA. baumanniiATCC 19606, which has been
shown to form a robust biofilm on both plastic and human skin
equivalents (4, 21, 27), attachment of strainAYE andATCC19606
cells to PVMwas imaged over 6 days by LIVE/DEAD staining and
confocal laser scanning microscopy (Fig. 2). Viability of the tissue
at 6 days was confirmed by imaging of uninfected tissue over the
same time course. Uninfected tissue stained green, indicating live,
intact cells with tight cell junctions (Fig. 2A to F). Epithelial cells
and bacteria were distinguishable from each other on the basis of
the size of the punctate staining, which could be clearly viewed by
confocalmicroscopy. Over the 6-day time course, strains AYE and
ATCC 19606 showed similar biofilm phenotypes. At 1 day posti-
noculation, loss of mucosal integrity was evidenced by rounding
of epithelial cells and adherent bacteria (small, bright green, punc-
tate staining) were visible on the tissue (Fig. 2G andM). By 3 days
postinoculation, epithelial cell death (red) was observed and the
number of bacteria visualized was greater (Fig. 2I and O). Black
areas indicated sloughing of cells, as the extracellular matrix does
not stain, and some biofilm formation was visible with ATCC
19606. By 6 days postinoculation, a large biofilm mass of both
strains was visible, few dead epithelial cells remained, andmost of
the tissue was covered by biofilm (Fig. 2L and R).
To investigate whether AdeRS is important for biofilm forma-
tion on biotic surfaces, the growth of strains AYE andAYEadeRS
on PVMwas measured. There was a rapid increase in the number
of adherent cells on PVM up to the 1-day time point, followed by
a slow but steady increase between 1 and 6 days (see Fig. S4 in the
supplemental material). There was no significant difference be-
tween the numbers of adherent cells of the parental and mutant
strains on days 1 to 6. However, LIVE/DEAD staining and confo-
cal laser scanning microscopy showed a difference between the
impact on the epithelial tissue of strains AYE and AYEadeRS
(Fig. 2). At 3 days postinoculation, strain AYE-infected tissue dis-
played epithelial cell death (red) (Fig. 2O), and by 6 days postin-
oculation, large biofilm masses and epithelial cell sloughing were
visible, as described above (Fig. 2R). However, for AYEadeRS,
although epithelial cell death was evident and the tissue exhibited
FIG 1 Accumulation of H33342 as determined by fluorescence. Markers
show H33342 fluorescence at steady state compared with that of the parental
strain in nine individual biological replicates, with horizontal lines represent-
ing the mean and vertical lines and whiskers showing the standard error of the
mean. FC, fold change.
FIG 2 Time course of biofilm development on mucosa, observed by LIVE/DEAD staining and confocal laser microscopy. Uninfected epithelia are live (green)
and intact throughout. Red, rounded epithelial cells indicate epithelial cell death. Small, punctate green staining indicates bacterial cells, and large, green-staining
masses indicate bacterial biofilm. Black areas depict the exposed extracellular matrix. Arrows indicate examples of live and dead epithelial cells, bacterial cells,
epithelial cell sloughing, and biofilmmasses. (A to F) Uninfected epithelial cells. (G to L) Growth of strain ATCC 19606 on mucosal tissue. (M to R) Growth of
parental strain AYE on mucosal tissue. (S to X) Growth of strain AYEadeRS on mucosal tissue.
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some epithelial cell sloughing, in contrast to coincubation with
AYE, many dead epithelial cells were still visible and a biofilm had
not covered the tissue. AYEadeRS cells appeared as single at-
tached cells, with no biofilm observed (Fig. 2V to X). These data
suggest a critical role for AdeRS inmucosal biofilm infections and
host cell cytotoxicity.
Deletion of adeRS in AYE results in no change in biofilm for-
mation on plastic. To investigate whether lack of AdeRS con-
ferred a change in biofilm formation on an abiotic surface, we
grew the parental strain AYE and the adeRS deletion mutant on
plastic pegs for 8 h. At that time point, the biofilm formedby strain
AYE was similar to that of previously characterized biofilm-
forming strain ATCC 19606 (a range of time frames had been
tested to determine the optimum length of time for biofilm
growth to be measured accurately; data not shown). Pegs were
then washed, and crystal violet staining was used to quantify bio-
film mass. In this in vitro model, compared with the parental
strain, there was no significant change in the biofilm mass pro-
duced by the adeRS deletion mutant at either 30°C or 37°C
(Fig. 3). There was also no detectable change in the amount of
pellicle formed in static cultures incubated for 48 h (data not
shown).
AYEadeRS is as virulent as AYE in G. mellonella. Previous
studies have shown a positive correlation between virulence in the
G. mellonella infection model and mammalian models (31, 32).
Furthermore, G. mellonella has been established as a good model
system to studyA. baumannii pathogenesis, as larvae can bemain-
tained at 37°C and have both a cellular and a humoral immune
response (33). In the G. mellonellamodel, compared with the pa-
rental strain, AYEadeRS showed a small but nonsignificant
change in virulence at an infectious dose of 106 CFU (Fig. 4).
Deletion of adeRS causes differential expression of func-
tional gene groups inA. baumanniiAYE.To understand the role
of the TCS AdeRS in the regulation of the expression of genes
involved in antimicrobial drug resistance, biofilm formation, and
virulence in A. baumannii strain AYE, changes in gene expression
in the TCS deletion mutant AYEadeRS were identified by RNA-
Seq (see Tables S1 to S3 in the supplemental material).
Loss of AdeRS had a large impact upon the transcriptome of
strain AYE, with the differential expression of 579 genes (308
genes with increased expression and 271 with decreased expres-
sion) (P  0.05). Differentially expressed genes were categorized
into clusters of orthologous groups (COGs) (34), and correlations
with the phenotypic changes seen in AYEadeRS were sought
(Fig. 5). First, differential expression of genes known to confer
antimicrobial resistance was identified. These included the RND
efflux pump genes adeABC, which showed 128-, 91-, and 28-fold
reductions in expression, respectively. One putative MDR RND
efflux pump (ABAYE3036) had 1.9-fold increased expression,
while the expression of another (ABAYE1796) was decreased by
1.5-fold. Genes encoding products with known and potential vir-
ulence functions, such as pili (35) and acinetobactin transport
systems (36), had significant (P  0.05) changes in expression
levels in AYEadeRS. For instance, there was increased expression
FIG 3 Biofilm formation on plastic pegs at 30°C and 37°C as determined by
crystal violet staining. Panels: A, 30°C; B, 37°C.Markers show fold change (FC)
in OD600 compared with the parental strain in individual biological replicates,
with horizontal lines representing the mean and vertical lines and whiskers
showing the standard error of the mean.
FIG 4 Kaplan-Meier survival curve showing the virulence of individual iso-
lates in G. mellonella. (A) adeRS and adeB mutants of strain AYE. (B) adeAB
mutant of strain S1. Data show percent survival (n 30) ofG. mellonella after
inoculation with 106 CFU of bacteria. Error bars represent the standard error
of the mean.
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of genes that encode motility, such as competence genes comB,
comC, comF, comL, comM, comN comO, and comQ (2.5- to 9.8-
fold). These genes putatively encode DNA uptake channels, and
deletion of comEC has been shown to reduce DNA uptake, motil-
ity, and virulence in G. mellonella (37). There was also increased
expression of pilB, pilC, pilD, pilG, pilH, pilI, pilJ, pilT, pilU, and
pilZ (1.7- to 8-fold). These genes encode type IV pili, which par-
ticipate in processes such as natural transformation and twitching
motility (37, 38). Type IV pili have also been associated with the
ability of A. baumannii to form a biofilm on plastic (39). Altera-
tions in the expression of other biofilm genes included the de-
creased expression of a pgaC-like gene (2-fold) that putatively
encodes a protein involved in the synthesis of cell-associated poly-
-(1-6)-N-acetylglucosamine, which is required for biofilm for-
mation on abiotic surfaces (7), and the decreased expression of
five putative biofilm genes, ABAYE0792, -1395, -1397, -1470, and
-1473 (1.7- to 2.5-fold). In addition, multiple putative transport
protein, outer membrane protein, and transcriptional regulator
FIG 5 RNA-Seq results displayed by COG functions. Panels: A, AYEadeRS; B, AYEadeB; C, S1adeAB.
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genes that lacked a comprehensive annotation showed differential
expression.
Type IV pili are required for motility in A. baumannii, and
inactivation of pilThas previously been shown to reduce twitching
motility (37, 38). To determine whether the increased expression
of motility genes correlated with altered motility, twitching mo-
tility and swarming experiments were carried out with 1%
Mueller-Hinton agar and 0.3% Luria-Bertani (LB) agar, respec-
tively (40). Strain AYE displayed twitching motility, typical of in-
ternational clone I, but did not display swarmingmotility, like the
majority of A. baumannii strains. However, no altered twitching
motility or swarming phenotype was detected in strain
AYEadeRS.
Deletion of adeB reduced efflux in AYE and S1 but only in-
creased drug susceptibility in AYE. Growth curves, determined
by measuring the OD of the culture over time, showed no differ-
ence in growth rate between either strains AYE and AYEadeB or
S1 and S1adeAB (see Fig. S1 in the supplemental material). To
determine whether deletion of adeB conferred a change in the
drug resistance profile of strain AYE, theMICs of commonly used
antibiotics, dyes, and biocides for strains AYE, AYEadeB, S1, and
S1adeAB were determined. There was a decrease in the MICs of
meropenem, imipenem, kanamycin, gentamicin, ciprofloxacin,
tetracycline, tigecycline, chloramphenicol, and ethidium bromide
upon the deletion of adeB from strain AYE (Table 1). All 2-fold
changes were confirmed by growth kinetics in the presence of
antibiotics (see Fig. S3 in the supplemental material). AYEadeB
had altered susceptibility to many of the same drugs as
AYEadeRS, but the MICs of kanamycin, gentamicin, and
ethidium bromide were lower after the deletion of adeB. Deletion
of adeAB from S1 only resulted in a decrease in the MIC of
phenylalanine-arginine -naphthylamide (PAN; an inhibitor of
AcrB and MexB, homologues of AdeB), although the MICs
of most drugs for S1 were much lower than those for strain AYE.
Compared with the steady-state accumulation level of the dye
H33342 in the parental strain, that in AYEadeBwas increased by
33% (P 0.05) (Fig. 1), indicating reduced levels of efflux in this
efflux pump gene deletion mutant. There was no difference be-
tween the accumulation of H33342 in S1adeAB and that in its
parental strain, S1; this was consistent with the minimal changes
in MICs (Fig. 1).
Deletion of adeB resulted in decreased biofilm formation of
AYE on plastic. To investigate whether AdeABC contributes to
A. baumannii biofilm formation, we grew parental strains AYE
and S1 and their isogenic efflux pumpmutants on plastic pegs for
8 h and quantified the biofilm masses as described previously.
Compared with the biofilm mass produced by the respective pa-
rental strains in this in vitromodel, there was a significant decrease
(P 0.05) in that produced by AYEadeB at both 30°C and 37°C
(Fig. 3). However, there was no change in biofilm formation by
S1adeAB at either temperature (Fig. 3). Therewas also no change
in the amount of pellicle formed in static cultures of AYEadeB
and S1adeAB incubated for 48 h (data not shown).
Deletion of adeB from AYE and adeAB from S1 results in
decreased biofilm formation on mucosal tissue. To determine
the role of AdeABC in biofilm formation on biotic surfaces, the
growth of strains AYE and S1 and their isogenic efflux pumpmu-
tants on PVM was measured as described previously. S1 showed
growth similar to that of strain AYE in terms of both adherent cell
counts (see Fig. S4 in the supplemental material) and biofilm im-
aging (Fig. 6). However, S1was able to form a robust biofilmmore
rapidly than strain AYE and a thick biofilm mat could be seen by
day 5 (Fig. 6Q), at which point the experiment was stopped. There
was no significant difference in the number of adherent cells on
FIG 6 Time course of biofilm development on mucosa observed by LIVE/DEAD staining and confocal laser microscopy. Uninfected epithelia are live (green)
and intact throughout. Red, rounded epithelial cells indicate epithelial cell death. Small, punctate green staining indicates bacterial cells, and large, green-staining
masses indicate bacterial biofilm. Black areas depict the exposed extracellular matrix. Arrows indicate examples of live and dead epithelial cells, bacterial cells,
epithelial cell sloughing, and biofilmmasses. (A to F) Growth of parental strain AYE onmucosal tissue. (G to L) Growth of strain AYEadeB onmucosal tissue.
(M to Q) Growth of parental strain S1 on mucosal tissue. (R to V) Growth of strain S1adeAB on mucosal tissue. Images are representative of at least three
repeated experiments.
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the tissue between either strains AYE and AYEadeB or S1 and
S1adeAB (see Fig. S4). However, compared with the respective
parental strains, both efflux pump mutants showed a defect in
biofilm formation when imaged by confocal microscopy. On days
5 and 6, S1 and AYE, respectively, formed large biofilm masses
with extensive epithelial cell sloughing (Fig. 6F and Q), whereas
although the mutants were able to cause epithelial cell death, only
individual bacterial cells were observed to be attached to the mu-
cosal tissue and less sloughing was evident (Fig. 6L and V). These
data suggest that the AdeABC efflux pump plays a key role in
biofilm formation onmucosal tissue and host cell cytotoxicity and
that the decreased production of this MDR efflux pump may be
responsible for the similar phenotype seen in strain AYEadeRS.
Deletion of adeAB from S1 results in attenuated virulence in
G. mellonella. S1adeAB displayed attenuated virulence in the
G. mellonella model, compared with that of S1. After infection
with S1, all larvae were dead by day 2, whereas 60%were still alive
on day 5 after infection with the mutant (Fig. 4). Strain AYE was
less virulent than S1 in G. mellonella, and there was no significant
difference in the killing of larvae by strains AYE and AYEadeB
(Fig. 4). This suggests a strain-specific role for AdeABC in the
virulence of A. baumannii.
Deletion of adeB causes differential gene expression in
A. baumannii AYE and S1. Compared with strain AYE,
AYEadeB had increased expression of 693 genes and decreased
expression of 477 genes (P 0.05). Comparedwith S1, S1adeAB
had increased expression of 164 genes and decreased expression of
119 genes (P 0.05). There were 108 genes with changed expres-
sion in both adeB mutants. Genes with increased expression in
AYEadeB included those encoding products with potential an-
tibiotic resistance functions such as a tetracycline resistance pro-
tein, TetA (1.4-fold);membrane fusion protein (MFP) AdeT (1.4-
fold), which is associated with MDR by active efflux in
A. baumannii (41); a putative porin protein associated with imi-
penem resistance (ABAYE0924) (4.3-fold); and two putative
MDR efflux systems (ABAYE1777, ABAYE3036) (1.4- and
3-fold). There was decreased expression of genes encoding a pu-
tative tetracycline resistance protein (ABAYE2235) (1.7-fold) and
the lipid phosphoethanolamine transferase EptA (2.5-fold),
which is associated with colistin resistance (42–44). Six
-lactamase genes (ABAYE0825, -1940, -2122, -2456, -3619, and
-3623) also had altered expression (2.2- to 50-fold) in AYEadeB.
The only gene related to drug resistance that displayed differential
expression, albeit only a small increase, in S1adeAB was that for
a putative MDR efflux system (ABAYE3036) (1.1-fold) that had
increased expression in all three deletion mutants. Similar to
strain AYEadeRS, genes encoding products with known and po-
tential virulence functions such as pili (35) and acinetobactin
transport systems (36) also had significant changes in expression
levels in adeB deletionmutants. The ferric acinetobactin transport
system operon bauDCEBA, which encodes proteins required for
persistence and virulence in the host (36, 45), had decreased ex-
pression inAYEadeB (1.9- to 3.7-fold). Themost striking change
observed in both efflux pump mutants was in cell motility genes.
The competence (com) genes which, as previously mentioned, are
associated with DNA uptake, motility, and virulence, had signifi-
cantly decreased expression in AYEadeB and S1adeAB (1.7- to
10-fold), in contrast to the significant increase in the expression of
these genes in strain AYEadeRS (Fig. 5). Likewise, there was a
significant decrease in the expression of the type IV pilus genes,
which are involved in natural transformation, twitching motility,
and biofilm formation. One other putative biofilm-associated
gene (ABAYE0792) showed increased expression (3-fold) in
AYEadeB, and no further genes with an annotated biofilm func-
tion were changed in S1adeAB. However, multiple putative
transcriptional-regulator-encoding genes (araC, lysR, and tetR
family) andoutermembrane protein-encoding genes that lacked a
comprehensive annotation had differential expression in both
mutants.
DISCUSSION
We have shown that deletion of the TCS AdeRS is associated with
decreased antibiotic resistance, epithelial cell killing, and biofilm
formation on mucosal tissue. We hypothesized that AdeRS regu-
lates the expression of genes, including the RNDMDR efflux sys-
tem genes adeABC, that are required for these functions. In strain
AYE, deletion of adeRS led to significant changes in the global
transcriptional landscape, with the changed expression of 579
genes, including 128-, 91-, and 28-fold changes in adeA, adeB, and
adeC expression, respectively. We show here that, in this strain,
deletion of adeB produces a phenotype similar to that caused by
the deletion of adeRS, consistent with the hypothesis that the phe-
notype ofAdeRSmutants is due to the decreased expression of this
RND MDR efflux pump. However, deletion of adeB from an un-
related strain, S1, resulted in reduced epithelial cell killing and
decreased biofilm formation on PVM but, in contrast to deletion
in strain AYE, had little effect on antibiotic resistance and resulted
in a reduction in virulence in G. mellonella. This suggests that
AdeABC has a strain-specific role in A. baumannii and may per-
form different functions in different strains.
AdeABC has a well-defined role in resistance to antimicrobials
in A. baumannii BM4587 (8, 46, 47). In our study, deletion of
adeRS or adeB from strain AYE resulted in a decrease in the MICs
of several antibiotics that have been previously described as sub-
strates of this pump (46, 47). This indicates that the downregula-
tion of adeABC in strain AYEadeRS is responsible for the change
in antibiotic susceptibility in this strain. Changes in MICs were
more pronounced upon the deletion of adeB than upon the dele-
tion of adeRS, which suggests that although deletion of adeRS
results in an up to 128-fold decrease in the expression of adeABC,
the efflux pump is still transcribed, albeit at a low level. We hy-
pothesize that this is also responsible for the difference in the
amounts of biofilm formed by these strains on plastic. While de-
letion of adeB from strain AYE resulted in a significant decrease in
biofilm formation at both 30°C and 37°C, deletion of adeRS had
no detectable effect. We hypothesize that low levels of expression
of adeABC in strain AYEadeRS are sufficient tomaintain biofilm
function, whereas inactivation of the pump in AYEadeB signifi-
cantly reduces the ability to form a biofilm.
Deletion of adeAB from a strain with a different background,
clinical isolate S1, also resulted in a phenotype different from that
seen in the strain AYE mutant: increased susceptibility to PAN
only. We hypothesize that the limited impact upon susceptibility
to antimicrobial drugs after inactivation of AdeAB in S1 is a result
of little change in the expression of adeABC between S1 and its
mutant. Although adeBwas expressed in S1, the level of expression
was 16-fold lower in S1 than in strain AYE, as compared by RNA-
Seq. This may explain the modest impact of the deletion of adeAB
from S1 upon this strain’s susceptibility to antibiotics andwhy it is
more susceptible to antibiotics than strain AYE is. Deletion of
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adeAB from S1 also had no significant effect on biofilm formation
on plastic; this may also be due to the small impact of deleting a
gene expressed at a low level.
In our study, only for AYEadeB was a significant biofilm de-
fect observed in the in vitro abiotic model. A similar observation
was previously shown in an adeB deletion mutant of drug-
susceptible A. baumannii BM4587 (47). However, all three of the
mutants tested in our study showed reduced biofilm formation on
mucosal tissue. The same phenotype was observed in AYEadeRS
and AYEadeB, with a significant decrease in epithelial cell killing
and biofilm formation seen in both. We hypothesize that the
downregulation of AdeABC in the former is responsible for this
biofilm defect. This suggests that regulation of adeABC is an im-
portant function of AdeRS in the ability ofA. baumannii to form a
biofilm on biotic surfaces. Although there was no change in the
number of adherent cells on the mucosal tissue upon the deletion
of adeRSor adeB, therewas a clear difference in the structure of the
biofilm when imaged by LIVE/DEAD staining and confocal laser
scanning microscopy. This is a phenomenon that has been previ-
ously observed in Staphylococcus aureus (20). This suggests that
while AdeB does not affect the initial attachment to tissue, cells
lacking this efflux pump are unable to form a mature biofilm on
mucosal tissue. Similar observations have been made in Salmo-
nella efflux pump mutants, which are able to adhere to surfaces
but are not able to produce a mature biofilm (48). PVM is made
up of stratified squamous epithelium, similar in structure to hu-
manmucosal surfaces (29). Furthermore, the growth characteris-
tics ofA. baumannii on the PVMwere similar to those observed in
a three-dimensional human skin equivalent model (26). There-
fore, differences in the ability of A. baumanniimutants to form a
biofilm in the PVM model may have implications for respiratory
and wound infections.
Despite a change in the expression of known (and putative)
genes associated with virulence in A. baumannii, such as the acin-
etobactin iron acquisition system and pilin genes, deletion of
adeRS or adeB from strain AYE had no effect on virulence in
G. mellonella. It is possible that AYE does not express the adeABC
efflux genes in vivo. In contrast, deletion of adeAB from S1 greatly
reduced virulence. The MFP-encoding gene adeA is also partially
deleted from strain S1, which may account for this difference.
Previous studies with other species have shown that some MFPs,
such as AcrA, can form a complex with multiple different RND
components, such as AcrB and AcrF (49, 50). The presence of
AdeA in strain AYE may allow it to interact with other proteins
and so compensate for the lack of AdeB and ameliorate any impact
upon virulence in this model. However, to our knowledge, so far,
no other A. baumannii efflux pumps have been shown to play a
role in virulence. Therefore, our data indicate a strain-specific role
for the AdeABC efflux pump in virulence. A correlation between
pathogenicity inG. mellonella and in humans has previously been
observed withA. baumannii (33). Therefore, our data suggest that
for some A. baumannii strains, such as S1, AdeABC may be re-
quired for infection of humans. The finding that the major RND
MDR efflux pump in A. baumannii can also play a fundamental
role in its ability to infect its host further underscores a role for
MDR efflux pumps in the basic biology of pathogenic bacteria.
Using transcriptome profiling, we have demonstrated that de-
letion of AdeRS results in altered transcription patterns compared
to those of the parental strain, thus highlighting its wider role in
gene regulation in A. baumannii. Deletion of AdeRS modulates
the expression ofmany genes, notably those associatedwithMDR,
epithelial cell killing, and biofilm formation. Our data suggest that
downregulation of the AdeABC efflux pump genes in the AYE
adeRS deletion mutant is responsible for the increase in suscepti-
bility to antimicrobials and the decrease in biofilm formation ob-
served in this strain. This is the first time, to our knowledge, that
this TCS has been associated with the regulation of biofilm forma-
tion in A. baumannii. Furthermore, we have shown a role for the
AdeABC efflux pump in biofilm formation on plastic andmucosal
tissue in an ex vivo model. These data suggest that inhibition of
MDR efflux pumps may be a useful strategy to help prevent or
treat colonization in patients by A. baumannii. Finally, we dem-
onstrate that two AdeB efflux pump deletion mutations in differ-
ent strains produced different virulence phenotypes in aG. mello-
nella model, highlighting the strain variability of A. baumannii.
This suggests that broad conclusions about the roles of specific
genes and proteins in the species should not be drawn from the
study of single strains.
MATERIALS AND METHODS
Strains, media, and chemicals. A. baumannii strain AYE is an MDR iso-
late that carries a mutation in adeS and is a member of epidemic clone II.
A. baumannii S1 (DR00539/06) is a more drug-sensitive clinical isolate
provided by the Network for Antimicrobial Resistance Surveillance (Sin-
gapore) and is representative of isolates causing infections in Singaporean
hospitals (51). Strains AYEadeRS, AYEadeB, and S1adeAB are un-
marked deletion mutants created by a previously described method for
generating markerless deletions in A. baumannii (28). Briefly, DNA frag-
ments upstream and downstream of the genes of interest were amplified
and ligated into a tellurite-resistant (sacB xylE) suicide vector,
pMo130-Telr. A two-step selection process was then used to select for
deletion mutants. Isolates S2 (DR01138/06), R2 (TTSH6013 654325/06),
and R3 (DM01800/06) are representative Singapore clinical isolates used
to compare the levels of adeB expression (28). Strain ATCC 19606 (ob-
tained from the American Type Culture Collection, Manassas, VA) was
used throughout as a reference strain with a previously characterized bio-
film phenotype (4). All strains were routinely cultured on LB agar or
tryptic soy agar II containing 5% sheep blood and in LB or Todd-Hewitt
broth. All chemicals were from Sigma-Aldrich (Poole, Dorset, United
Kingdom).
Measurement of bacterial growth. Bacterial strains were grown with
aeration in LB broth at 37°C overnight. A total of 200 l of culture was
added to eachwell of a clear 96-wellmicrotiter tray (MTT) at an inoculum
density of 104 CFU/ml. OD at 600 nm (OD600) was measured over 16 h in
a BMG FLUOstar OPTIMA (BMG, United Kingdom) at 37°C. The dif-
ference in the final OD600 at 16 h was calculated, and values returning a
P value of0.05 from a Student t test were taken as significant.
RNA-Seq. RNA was extracted from a minimum of three biological
replicates of each strain with a Qiagen RNAprotect Bacteria Reagent and
RNeasy minikit and DNase treated with an Ambion TURBO DNA-free
kit. RNA libraries were prepared and sequenced with an Illumina MiSeq
or HiSeq at ARK Genomics, Roslin Institute, University of Edinburgh,
University of Birmingham, or BGIGenomics,HongKong. Raw sequences
were assessed for quality with FASTQC and processed. Alignments with a
strain AYE reference genome (52) were performed with bowtie2. A bed
file of the gene loci was generated from the gff annotation, and bedtools
was used to count tags overlapping the regions of interest. Raw tag counts
per sample were scale normalized to the sample by using the lowest num-
ber of tags within each data set. Counts were converted to log2 and quan-
tile normalized within each series for comparisons within each data set.
Pairwise comparisons of the normalized tag counts were performed by
linear modeling (Bioconductor limma package). A raw P cutoff value of
0.05 was used to produce a list of changed genes that could be verified by
phenotypic testing. No fold change cutoff was used.
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Measurement of efflux activity. Efflux activity was determined by
measuring the accumulation of H33342. The H33342 (bis-benzimide)
assay was carried out as described previously (53). Steady-state fluores-
cence values were taken and converted to fold changes compared to the
parental strain. The differences between parent and mutant strains were
calculated, and values returning a P value of0.05 from a Student t test
were taken as significant.
Determinationof antimicrobial susceptibility.TheMICs of ampicil-
lin, ceftazidime, kanamycin, gentamicin, norfloxacin, ciprofloxacin,
colistin, tetracycline, tigecycline, chloramphenicol, carbonyl cyanide
m-chlorophenylhydrazone, PAN, and ethidium bromide were deter-
mined by the agar doubling dilution method according to British Society
for Antimicrobial Chemotherapy standard methodology (54). MICs of
imipenem and meropenem were determined by E test (bioMérieux,
Hampshire, United Kingdom). Clinically relevant resistance was defined
as a MIC above the recommended breakpoint according to the EUCAST
guidelines (55). All experiments were carried out in triplicate.
Measurement of biofilm formation on plastic. Biofilm formation on
plastic was measured with an adapted version of a previously described
method (56). Wells of an MTT were inoculated with 100 l of diluted
culture, and a sterile, 96-well polystyrene PCR plate was placed into the
MTT. Plates were incubated for 8 h at either 30°C or 37°C. Pegs were
washed and stained with 1% crystal violet for 15 min. Dye was solubilized
in 70% ethanol, andOD600 wasmeasuredwith a BMGFLUOstar Optima.
OD600 was converted to fold change compared to the parental strain in
order to compare results between experiments. The differences between
parent and mutant strains were calculated, and values returning a P value
of0.05 from a Student t test were taken as significant.
Measurement of biofilm formation on PVM tissue. Biofilm forma-
tion onmucosal tissue wasmeasured as described previously (29). Briefly,
specimens of normal PVM were excised from animals at slaughter and
washed in RPMI 1640medium (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal calf serum (Invitrogen), penicillin (50 IU/ml;MPBiomedi-
cals, Solon, OH), streptomycin (50g/ml;MPBiomedicals), and ampho-
tericin B (2.5 g/ml; HyClone, Logan, UT); 5-mm tissue explants were
cut; and excessmuscle was trimmed away. Tissue explants were washed in
serum- and antibiotic-free medium three times. Explants were then
placed mucosal side up on a 0.4-m cell culture insert (BD Bioscience,
San Jose, CA, USA) in six-well plates containing fresh serum- and
antibiotic-free RPMI 1640 medium. Explants were inoculated with
105 CFU of bacteria and incubated at 37°C. Adherent and planktonic cells
were counted at 24, 48, 72, 96, 120, and 144 h. The difference in the
number of adherent cells between parent and mutant strains was calcu-
lated, and values returning a P value of0.05 from a Student t test were
taken as significant. For imaging, explants were stained with a FilmTracer
LIVEDEAD Biofilm Viability kit (Invitrogen, Carlsbad, CA) according to
the manufacturer’s instructions. The LIVE/DEAD stain consists of
SYTO9, which stains live cells green, and propidium iodide (PI), which
stains dead cells red. PI penetrates only cells with damaged membranes,
and once it is in close proximity to SYTO9, it quenches the green signal, so
only the red is visible. This allows live versus dead cells to be detected.
These dyes are nonspecific nucleic acid dyes that do not discern between
prokaryotic and eukaryotic cells (29, 57–59). After staining, specimens
were gently washed three times in Hanks’ balanced salt solution and
transferred to glass slides. A coverslip with a 1-mm spacer (Electron
Microscopy Sciences, Hatfield, PA) was then applied, and specimens
were imaged on an Olympus FluoView 1000 BX2 (Olympus America
Corporation, Center Valley, PA) with a 60 oil immersion objective.
Images were captured and processed with FluoView software (Olym-
pus America Corporation, Center Valley, PA).
Measurement of motility. Swarming and twitching motility was
measured as described previously (40). Briefly, a single colony was
used to inoculate petri dishes containing 0.3% LB agar or 1%Mueller-
Hinton agar. Plates were incubated overnight at 37°C and examined
for growth.
Measurement of virulence inG. mellonella. Survival in G. mellonella
was assayed as previously described (60). Bacteria were injected into
G. mellonella larvae in an inoculum of 106 CFU. Larvae were incubated
statically at 37°C in petri dishes, and the number of dead larvae was scored
periodically. All experiments were carried out in triplicate, and statistical
analysis was carried out with GraphPad Prism 5 to produce Kaplan-Meier
survival curves. The statistical significance of differences between parent
and mutant strain survival curves was calculated with a log rank test.
P values of0.05 were taken as significant.
Ethics statement.No animals were used in this study. Porcine tissue is
not subject to regulation, as it is a by-product of the slaughter of animals
for food.
Microarray data accession numbers. The RNA-Seq data obtained in
this study were submitted to ArrayExpress (accession no. E-MTAB-4047,
E-MTAB-4049, and E-MTAB-4071).
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Erratum for Richmond et al., The Acinetobacter baumannii Two-
Component System AdeRS Regulates Genes Required for Multidrug
Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner
Grace E. Richmond,a Laura P. Evans,a Michele J. Anderson,b Matthew E. Wand,c Laura C. Bonney,c Alasdair Ivens,d Kim Lee Chua,e
Mark A. Webber,a J. Mark Sutton,c Marnie L. Peterson,b Laura J. V. Piddocka
Antimicrobial Agents Research Group, Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdoma; Department of
Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USAb; Public Health England, Microbiology Services Division, Porton Down,
Salisbury, United Kingdomc; Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdomd; Department of Biochemistry, Yong Loo
Lin School of Medicine, National University of Singapore, Singaporee
Volume 7, no. 2, doi:10.1128/mBio.00430-16, 2016. After careful review, it has come to our attention that the text in the abstract ofour paper is at variance with one sentence in the article. During writing, revision, and editing, the sense was changed. The revised
abstract below shows the correct text. We thank Maria Ramirez for bringing this to our attention.
The opportunistic pathogen Acinetobacter baumannii is able to persist in the environment and is often multidrug resistant (MDR),
causing difficulties in the treatment of infections. Here, we show that the two-component system AdeRS, which regulates the produc-
tion of the AdeABCmultidrug resistance efflux pump, is required for the formation of a protective biofilm in an ex vivo porcinemucosal
model, which mimics a natural infection of the human epithelium. Interestingly, deletion of adeB impacted on the ability to form a
biofilm on plastic for strain AYE only and on the virulence inGalleria mellonella for Singapore strain 1 only. RNA-Seq revealed that loss
of AdeRS or AdeB significantly altered the transcriptional landscape, resulting in the changed expression of many genes, notably those
associated with antimicrobial resistance and virulence interactions. For example, A. baumannii lacking AdeRS displayed decreased
expression of adeABC and a pgaC-like gene and increased expression of pil and com genes, whereas loss of AdeB resulted in decreased
expression of pil, com, and ferric acinetobactin transport system genes. These data define the scope of AdeRS-mediated regulation, show
that changes in the production of AdeABC mediate important phenotypes controlled by AdeRS, and suggest that AdeABC is a viable
target for antimicrobial drug and anti-biofilm discovery.
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